Compass Pathways is a mental health care company developing a psilocybin-based treatment method for neurological disorders. In 2020, the company held a $80 million funding round. Compass has already been challenged by the law firm Kohn and Associates, which claims its patents are too broad and has initiated a review process.
Loading Documents... |